26.05.2024, 706 Zeichen

Valneva: Valneva, a specialty vaccine company, today announced the appointment of Dr. Hanneke Schuitemaker, Ph.D. as Chief Scientific Officer (CSO) and Executive Committee member, effective June 3, 2024. Dr. Schuitemaker brings more than two decades of experience in vaccine discovery and development. She formerly served as Global Head of Viral Vaccine Discovery and Translational Medicine at Johnson & Johnson (J&J), with responsibility for the strategy and execution of vaccine programs on COVID-19, HIV, RSV, Ebola, and multiple other viral disease targets for almost 14 years.
Valneva: weekly performance: -5.37%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (20/05/2024)

Christian Drastil: Wiener Börse Plausch

kapitalmarkt-stimme.at daily voice 111/365: Ö1 fragt, was der Broker eigentlich für ein Menschenschlag rein soziologisch betrachtet ist

Bildnachweis

Aktien auf dem Radar:Frequentis, Porr, Österreichische Post, Addiko Bank, Pierer Mobility, RHI Magnesita, Verbund, EVN, CPI Europe AG, Bawag, VIG, OMV, Telekom Austria, Uniqa, Amag, Wolford, Oberbank AG Stamm, Marinomed Biotech, CA Immo, Erste Group, FACC, Kapsch TrafficCom, Polytec Group, RBI, Rosenbauer, SBO, Semperit, Strabag, Wienerberger, Flughafen Wien, Fresenius Medical Care.

---